Physician profile
Sameh Hanna
NPI 1922182336
$935.04
in general payments reported to CMS, 2019-2025
14 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $59.65 · 2022: $40.03 · 2023: $137 · 2024: $63.86 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $166.12 | 2019-2020 | |
| Boston Scientific Corporation | $138.92 | 2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Nevro Corp. | $138.66 | 2019 | |
| Sentynl Therapeutics, INC. | $125.67 | 2019 | |
| Abbvie INC. | $115.48 | 2022-2025 | |
| Averitas Pharma INC. | $86.93 | 2023 | Qutenza |
| Medtronic, INC. | $31.73 | 2024 | Intellis Adaptivestim |
| Braeburn INC. | $27.27 | 2025 | Brixadi |
| Indivior INC. | $21.78 | 2022 | |
| Shionogi INC | $20.81 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.87 | 2025 | |
| Lilly USA, LLC | $16.30 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $14.62 | 2020 | |
| Biodelivery Sciences International, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.